CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $27,000 | -28.9% | 10,883 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $38,000 | +2.7% | 10,883 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $37,000 | -15.9% | 10,883 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $44,000 | 0.0% | 10,883 | +6.9% | 0.00% | -33.3% |
| Q2 2016 | $44,000 | -85.6% | 10,185 | +18.0% | 0.00% | -88.5% |
| Q3 2013 | $305,000 | – | 8,633 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $24,302,000 | 100.00% |
| TSP Capital Management Group, LLC | 886,398 | $3,138,000 | 1.60% |
| Marcus Capital, LLC | 109,950 | $389,000 | 0.42% |
| RTW INVESTMENTS, LP | 239,662 | $848,000 | 0.32% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 6,195,855 | $21,933,000 | 0.31% |
| Benchmark Capital Advisors | 66,800 | $236,000 | 0.20% |
| Bellevue Group AG | 160,000 | $566,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 632,944 | $2,241,000 | 0.09% |
| PDT Partners, LLC | 369,300 | $1,307,000 | 0.09% |
| Vident Investment Advisory, LLC | 196,715 | $696,000 | 0.08% |